Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

2002; Massachusetts Medical Society; Volume: 346; Issue: 23 Linguagem: Inglês

10.1056/nejmoa012843

ISSN

1533-4406

Autores

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa, Jean Fajadet, Ernesto Ban Hayashi, Marco Perin, Antonio Colombo, Gerhard Schüler, Paul Barragan, Giulio Guagliumi, Ferenc Molnár, Robert Falotico,

Tópico(s)

Cardiac and Coronary Surgery Techniques

Resumo

The need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris.

Referência(s)